246 related articles for article (PubMed ID: 32366782)
41. Bilateral segmental neurofibromatosis: a case report and review.
Gonzalez G; Russi ME; Lodeiros A
Pediatr Neurol; 2007 Jan; 36(1):51-3. PubMed ID: 17162198
[TBL] [Abstract][Full Text] [Related]
42. Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.
Kaufmann D; Müller R; Bartelt B; Wolf M; Kunzi-Rapp K; Hanemann CO; Fahsold R; Hein C; Vogel W; Assum G
Am J Hum Genet; 2001 Dec; 69(6):1395-400. PubMed ID: 11704931
[TBL] [Abstract][Full Text] [Related]
43. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
44. [A case of growth hormone deficiency combined with neurofibromatosis Type 1 and its gene analysis].
Long X; Xiong J; Mo Z; Zhang Q; Jin P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):811-815. PubMed ID: 30124220
[TBL] [Abstract][Full Text] [Related]
45. Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients.
Kaufmann D; Bartelt B; Hoffmeyer S; Müller R
Arch Dermatol Res; 1999 Jun; 291(6):312-7. PubMed ID: 10421056
[TBL] [Abstract][Full Text] [Related]
46. A porcine model of neurofibromatosis type 1 that mimics the human disease.
White KA; Swier VJ; Cain JT; Kohlmeyer JL; Meyerholz DK; Tanas MR; Uthoff J; Hammond E; Li H; Rohret FA; Goeken A; Chan CH; Leidinger MR; Umesalma S; Wallace MR; Dodd RD; Panzer K; Tang AH; Darbro BW; Moutal A; Cai S; Li W; Bellampalli SS; Khanna R; Rogers CS; Sieren JC; Quelle DE; Weimer JM
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925695
[TBL] [Abstract][Full Text] [Related]
47. NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1.
Muram-Zborovski TM; Vaughn CP; Viskochil DH; Hanson H; Mao R; Stevenson DA
Am J Med Genet A; 2010 Aug; 152A(8):1973-8. PubMed ID: 20602485
[TBL] [Abstract][Full Text] [Related]
48. Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature.
Castle AMR; Empringham B; Pinto LM; Villani A; Kanwar N; Abbott LS; Sawyer SL
Pediatr Hematol Oncol; 2023; 40(5):506-515. PubMed ID: 36625737
[TBL] [Abstract][Full Text] [Related]
49. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
[TBL] [Abstract][Full Text] [Related]
50. A novel mutation in NF1 gene of patient with Neurofibromatosis type 1: A case report and functional study.
Zhang T; Jia C; Dong Z; Li C; Lu W
Mol Genet Genomic Med; 2021 May; 9(5):e1643. PubMed ID: 33764694
[TBL] [Abstract][Full Text] [Related]
51. Café-au-lait macules and intertriginous freckling in piebaldism: clinical overlap with neurofibromatosis type 1 and Legius syndrome.
Stevens CA; Chiang PW; Messiaen LM
Am J Med Genet A; 2012 May; 158A(5):1195-9. PubMed ID: 22438235
[TBL] [Abstract][Full Text] [Related]
52. Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis.
Burkitt Wright EM; Sach E; Sharif S; Quarrell O; Carroll T; Whitehouse RW; Upadhyaya M; Huson SM; Evans DG
J Med Genet; 2013 Sep; 50(9):606-13. PubMed ID: 23812910
[TBL] [Abstract][Full Text] [Related]
53. Café au lait spots: When and how to pursue their genetic origins.
Lalor L; Davies OMT; Basel D; Siegel DH
Clin Dermatol; 2020; 38(4):421-431. PubMed ID: 32972601
[TBL] [Abstract][Full Text] [Related]
54. The absence that makes the difference: choroidal abnormalities in Legius syndrome.
Tucci A; Saletti V; Menni F; Cesaretti C; Scuvera G; Esposito S; Melloni G; Esposito S; Milani D; Cereda C; Cigada M; Tresoldi L; Viola F; Natacci F
J Hum Genet; 2017 Nov; 62(11):1001-1004. PubMed ID: 28747691
[TBL] [Abstract][Full Text] [Related]
55. NF1 frameshift mutation (c.6520_6523delGAGA) association with nervous system tumors and bone abnormalities in a Chinese patient with neurofibromatosis type 1.
Su SY; Zhou X; Pang XM; Chen CY; Li SH; Liu JL
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173220
[TBL] [Abstract][Full Text] [Related]
56. Familial evaluation reveals a distinct genetic cause in a large Spanish family with neurofibromatosis 1 and hypertrophic cardiomyopathy.
Salazar-Mendiguchía J; Díez-López C; Claver E; Cesar S; Campuzano O; Sarquella-Brugada G; Monserrat L
Gene; 2020 Jul; 746():144658. PubMed ID: 32283115
[TBL] [Abstract][Full Text] [Related]
57. Lisch nodules and skin manifestation in neurofibromatosis type 1.
Otsuka F; Kawashima T; Imakado S; Usuki Y; Hon-Mura S
Arch Dermatol; 2001 Feb; 137(2):232-3. PubMed ID: 11176707
[No Abstract] [Full Text] [Related]
58. Segmental neurofibromatosis and malignancy.
Dang JD; Cohen PR
Skinmed; 2010; 8(3):156-9. PubMed ID: 21137621
[TBL] [Abstract][Full Text] [Related]
59. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
60. Further Lessons Learned From a Child With NF1 and Classical Hodgkin Lymphoma.
Carter Febres M; Viskochil D; Rampton J; Afify Z
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e743-e744. PubMed ID: 32925410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
